Streetbeat News

Products Services

MRNA

Moderna, Inc. (NASDAQ:MRNA) is restructuring its operating model to prioritize sales of its COVID-19 vaccine, Spikevax, and the upcoming launch of its RSV vaccine in 2024. CEO Stephane Bancel will take charge of sales and marketing, while President Stephen Hoge will oversee pipeline commercial strategy and Medical Affairs. Arpa Garay, the outgoing Chief Commercial Officer, will advise during the transition before leaving the company.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:06 pm

PRSO

Peraso Inc. (NASDAQ: PRSO) has announced a new customer partnership for its X130 chipset, signaling growth and expansion into high-volume consumer markets. The X130 chipset, featuring the PRS1145 and PRS4601 ICs, will be used for wireless video distribution, replacing the customer's existing solution. It supports high bandwidth and low latency applications, avoiding Wi-Fi congestion by using mmWave technology. The X130 is designed for applications like wireless AR/VR, displays, docking, and cloud access, and includes advanced features such as beamforming, beam tracking, and AES security.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:03 pm

PSTV

Plus Therapeutics has entered into a partnership with K2bio to develop new tests for analyzing tumor cells and molecular biomarkers in cerebrospinal fluid (CSF). This collaboration aims to advance the diagnosis and monitoring of central nervous system (CNS) cancers. The partnership could potentially lead to more effective treatments and improved patient outcomes by enabling better detection and understanding of CNS malignancies.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:02 pm

VIRX

Viracta Therapeutics announced that the FDA has granted Orphan Drug Designation to its drug Nana-val for the treatment of Nasopharyngeal Carcinoma, a type of cancer that occurs in the nasopharynx.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:01 pm

HCDI

ICVX

ORCL

Icosavax, Inc. (NASDAQ:ICVX) shares surged approximately 45% in pre-market trading following AstraZeneca's announcement of plans to acquire Icosavax for up to $1.1 billion. Icosavax also reported positive interim Phase 2 results for its IVX-A12 vaccine candidate. Other stocks experiencing pre-market movements include gainers Bruush Oral Care Inc. (BRSH), Connect Biopharma Holdings Limited (CNTB), and losers Harbor Custom Development, Inc. (HCDI), which filed for Chapter 11 bankruptcy, and Oracle Corporation (ORCL), which reported mixed quarterly results.

Portfolio Pulse from Avi Kapoor

December 12, 2023 | 1:00 pm

GOOG

GOOGL

QCOM

A user's Google Pixel 6 Pro, powered by Alphabet Inc.'s custom Google Tensor chipset, overheated and died after a 10-minute phone call. The overheating issue is not isolated to the Pixel 6 Pro but also affects the newer Pixel 8, which uses the third-generation Tensor chipset. Despite new generations of the chipset, Google has not resolved the overheating problem, with the Pixel 8 Pro reaching temperatures close to the iPhone 15 Pro. The Tensor G3 chipset's performance is comparable to Qualcomm Inc.'s Snapdragon 8+ Gen 1 chipset from 2022.

Portfolio Pulse from Rounak Jain

December 12, 2023 | 1:00 pm

NFLX

TSLA

Elon Musk, CEO of Tesla Inc., made a comment on a Netflix movie clip from 'Leave the World Behind' that showed Tesla vehicles in a doomsday scenario. Musk's remark highlighted Tesla's ability to charge from solar panels even in extreme conditions, which seemed out of context with the movie's theme of hacked self-driving Teslas causing chaos. The movie, a collaboration involving Higher Ground Productions and notable actors, is currently streaming on Netflix.

Portfolio Pulse from Anan Ashraf

December 12, 2023 | 12:37 pm

STRM

Streamline Health Solutions has broadened its existing agreement with a five-hospital health system in Pennsylvania, integrating eValuator's Pro-Fee pre-bill coding analysis technology to enhance revenue integrity and financial performance for professional fee services.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:35 pm

DASH

PAR

PAR Technology has formed a partnership with DoorDash to integrate DoorDash with PAR's Brink POS and MENU Link, enhancing the omnichannel ordering experience.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:35 pm

PTGX

Protagonist Therapeutics, Inc. presented two-year follow-up data from the Phase 2 REVIVE study of rusfertide at the ASH Annual Meeting. Rusfertide is a hepcidin mimetic with potential in treating polycythemia vera and other diseases. The presentations are available on the company's website.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:34 pm